Phase variation in Bartonella henselae
- 1 March 2003
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 149 (3) , 621-629
- https://doi.org/10.1099/mic.0.26014-0
Abstract
Bartonella henselae is a fastidious, Gram-negative bacterial pathogen of cats and humans. Previous workers have shown that serial passage in vitro leads to attenuation of virulence-associated attributes such as expression of pili, invasion of human epithelial cell lines and the stimulation of endothelial cell proliferation. In contrast to the published data, it was found that pilin expression is frequently preserved in organisms which have undergone phase variation in vitro. Transition from a slow-growing, dry agar-pitting (DAP) to a faster-growing, smooth non-agar-pitting (SNP) form appears to occur predictably and may reflect competition between two populations growing at different rates. Better survival of the slower-growing (DAP) form may explain its relatively easy retrieval from piliated SNP populations allowed to age on solid media. Pilin expression is associated with auto-agglutination in liquid suspension or broth cultures, and appears to be necessary but not sufficient for expression of the agar-pitting phenotype and for the formation of biofilms. Outer-membrane protein variation is seen in association with phase variation, but lipopolysaccharide expression is preserved in piliated as well as extensively passaged non-piliated isolates. The EagI/HhaI infrequent restriction site-PCR fingerprint, which has been previously used to discriminate between serotypes Marseille and Houston, is shown to alter with phase variation in vitro, and there is evidence that genetic change accompanies these events. The extent of genetic and phenotypic variability of phase-variant B. henselae has previously been underestimated. It may lead to new insights into the pathogenicity of this organism, and must be considered when interpreting data arising from such studies.Keywords
This publication has 28 references indexed in Scilit:
- Evidence of a leading role for VEGF inBartonella henselae-induced endothelial cell proliferationsCellular Microbiology, 2001
- Editorial Response: Are allBartonella henselaeStrains Created Equal?Clinical Infectious Diseases, 1998
- Analysis of a 36-Kilodalton Protein (PapA) Associated with the Bacteriophage Particle ofBartonella henselaeDNA and Cell Biology, 1997
- Bartonella henselaebacteraemia in domestic cats from AucklandNew Zealand Veterinary Journal, 1997
- Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an australian cat populationPathology, 1996
- Lipopolysaccharide with an altered O‐antigen produced in Escherichia coli K‐12 harbouring mutated, cloned Shigella flexneri rfb genesMolecular Microbiology, 1995
- Bacteriophage‐like particle of Rochalimaea henselaeMolecular Microbiology, 1994
- Downregulation of Human Polymorphonuclear Cell Activities Exerted by Microorganisms Belonging to the α-2 Subgroup of Proteobacteria (Afipia Fs and Rochallmaea Henselae)Immunopharmacology and Immunotoxicology, 1994
- Electrophoretic resolution of the ‘major outer membrane protein’ of Escherichia coli K12 into four bandsFEBS Letters, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970